相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Thyroid Hormone Inactivation in Gastrointestinal Stromal Tumors
Theodoros Foukakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Attitudes of patients with metastatic breast cancer toward research biopsies
D. S. Seah et al.
ANNALS OF ONCOLOGY (2013)
AffyRNADegradation: control and correction of RNA quality effects in GeneChip expression data
Mario Fasold et al.
BIOINFORMATICS (2013)
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials
Francois-Clement Bidard et al.
CANCER AND METASTASIS REVIEWS (2013)
18F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO
Geraldine Gebhart et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety
C. A. Gomez-Roca et al.
ANNALS OF ONCOLOGY (2012)
When to order a biopsy to characterise a metastatic relapse in breast cancer
T. Foukakis et al.
ANNALS OF ONCOLOGY (2012)
Biopsy of liver metastasis for women with breast cancer: Impact on survival
Edoardo Botteri et al.
BREAST (2012)
First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study
Jonas Bergh et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression
Linda Sofie Lindstrom et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer
Eitan Amir et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Practical implications of gene-expression-based assays for breast oncologists
Aleix Prat et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Hurdles in anticancer drug development from a regulatory perspective
Bertil Jonsson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Biospecimen Reporting for Improved Study Quality (BRISQ)
Helen M. Moore et al.
CANCER CYTOPATHOLOGY (2011)
Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene
F. M. Buffa et al.
BRITISH JOURNAL OF CANCER (2010)
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
Torsten O. Nielsen et al.
CLINICAL CANCER RESEARCH (2010)
Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS)
Alastair M. Thompson et al.
BREAST CANCER RESEARCH (2010)
Quo Vadis With Targeted Drugs in the 21st Century?
Jonas Bergh
JOURNAL OF CLINICAL ONCOLOGY (2009)
Circulating Tumor Cells and [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Outcome Prediction in Metastatic Breast Cancer
Ugo De Giorgi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
arrayQualityMetrics—a bioconductor package for quality assessment of microarray data
Audrey Kauffmann et al.
BIOINFORMATICS (2008)
Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane
Harold J. Burstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Powerful prognostic stratification by [18F] fluorodeoxyglucose positron emission tomography in patients with metastatic breast cancer treated with high-dose chemotherapy
Florent Cachin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Proteinase K added to the extraction procedure markedly increases RNA yield from primary breast tumors for use in microarray studies
S Egyházi et al.
CLINICAL CHEMISTRY (2004)
affy -: analysis of Affymetrix GeneChip data at the probe level
L Gautier et al.
BIOINFORMATICS (2004)
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
AM O'Farrell et al.
BLOOD (2003)
分享论文
